Finding the Best Treatments for the Fight Against Cancer

nsf, national science foundation, sciencelives, sl, Mona Jhaveri, Activate, Foligo Therapeutics, biochemistry, cancer, breast cancer, ovarian cancer, therapeutics, business, entrepreneur, ACTiVATE, ACTiVATE Series
Mona Jhaveri of Foligo Therapeutic.
(Image credit: Foligo Therapeutics, Inc.)

This ScienceLives article was provided to LiveScience in partnership with the National Science Foundation.

Mona S. Jhaveri founded Foligo Therapeutics, Inc. in 2006, a start-up biotech company developing molecular-based therapeutics and "companion" diagnostics for the treatment of ovarian cancer and other cancers. Jhaveri completed her doctorate in biochemistry at Wake Forest University. From 1997-2001 Jhaveri trained as a post-doctoral fellow at the National Cancer Institute in Bethesda, Md., where she discovered FOLIGO's lead therapeutic compound, FOLIGO 002.

Latest Videos From
Foligo Therapeutics